Effectiveness of Clopidogrel and Aspirin Versus Ticlopidine and Aspirin in Preventing Stent Thrombosis After Coronary Stent Implantation
Circulation1999Vol. 99(18), pp. 2364–2366
Citations Over TimeTop 1% of 1999 papers
Issam Moussa, Mathew Oetgen, Gary S. Roubin, Antonio Colombo, Xangdong Wang, Sriram S. Iyer, Roberta Maida, Michael J. Collins, Edward M. Kreps, Jeffrey W. Moses
Abstract
These data suggest that clopidogrel may be an effective pharmacological regimen after coronary stent implantation. Furthermore, the simpler dosing regimen, the absence of neutropenia, and the lower frequency of other side effects make it a safe alternative to ticlopidine.
Related Papers
- → Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: Evidence from a meta-regression(2007)17 cited
- → Routine pre-treatment with clopidogrel before diagnostic coronary angiography: the question is right, but what about the answer?(2008)2 cited
- → Rationale and Role of High Loading Dose Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention(2012)2 cited
- Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis.(2004)
- [Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?].(2003)